Actualités et annonces

Le Medicines Patent Pool et Pharco Pharmaceuticals signent un nouvel accord de licence portant sur le ravidasvir, un médicament candidat prometteur contre l’hépatite C

La TB Alliance sous-licencie un médicament prometteur contre la tuberculose au Medicines Patent Pool

[EN] Access to Medicine Index 2016 Published Today with High Marks for Companies that Licence to the Medicines Patent Pool (MPP)

Evenements à venir

Faits marquants

(EN) MPP-WHO event – Forecasts vs. Reality: Are we on Course?

Access the presentations

(EN) Opening remarks by Dr. Ren Minghui (WHO) at MPP-WHO joint event

Read the statement

(EN) MPP’s Winter Newsletter

The MPP publishes its February 2017 newsletter featuring an update on its last six months of progress.

(EN) Invitation to submit interest in a sub-licence for sutezolid

Read more

(EN) The MPP Intervention on Intellectual Property, 39th Meeting of the UNAIDS Programme Coordinating Board, December 7, 2016

Read the statement